Tubulointerstitial ACE2 mRNA was decreased in patients with hypertensive nephrosclerosis and correlated with the degree of renal failure [39], and kidney ACE2 mRNA was reduced patients with type 2 diabetes and overt nephropathy [40]; neither study measured urinary ACE2 activity. This evidence concerns the gene ACE2 and type 2 diabetes mellitus.